P. Eerdmans

发表

Biolimus-eluting stent with biodegradable polymer improves clinical outcomes in patients with acute myocardial infarction

P. Serruys, J. Iqbal, S. Windecker, 2014, Heart.

The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer.

F. Eberli, P. Serruys, P. Jüni, 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial.

M. Morice, P. Urban, P. Brunel, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel.

Deepak L. Bhatt, Sunil V. Rao, S. Pocock, 2020, Journal of the American College of Cardiology.

The impact of body mass index on the one year outcomes of patients treated by percutaneous coronary intervention with Biolimus- and Sirolimus-eluting stents (from the LEADERS Trial).

Dick M. Goedhart, F. Eberli, P. Serruys, 2010, The American journal of cardiology.

Five-year outcomes of chronic total occlusion treatment with a biolimus A9-eluting biodegradable polymer stent versus a sirolimus-eluting permanent polymer stent in the LEADERS all-comers trial.

P. Serruys, J. Wykrzykowska, S. Windecker, 2016, Cardiology journal.

Mesenteric Small Artery Changes After Vasoconstrictor Infusion in Young Rats

M. Daemen, J. D. De Mey, P. Eerdmans, 1993, Journal of cardiovascular pharmacology.

The effect in vitro of irrigating solutions on intact rat articular cartilage.

S. Bulstra, R. Kuijer, P. Eerdmans, 1994, The Journal of bone and joint surgery. British volume.

Sympathetic nerves and alterations in vascular structure and reactivity

P. Eerdmans, 1997 .

An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study.

P. Serruys, S. Windecker, Simon Wandel, 2010, European heart journal.

Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease Final 5-Year Report (Limus Eluted From A Durable Versus ERodable Stent Coating) Randomi

F. Eberli, P. Serruys, S. Windecker, 2022 .

Sacral Root Neuromodulation in the Treatment of Refractory Urinary Urge Incontinence: A Prospective Randomized Clinical Trial

B. Bemelmans, R. Janknegt, P. Eerdmans, 2000, European Urology.

Clinical results of sacral neuromodulation for chronic voiding dysfunction using unilateral sacral foramen electrodes

R. Janknegt, P. Eerdmans, P. V. van Kerrebroeck, 1998, World Journal of Urology.

Improving neuromodulation technique for refractory voiding dysfunctions: two-stage implant.

P. Eerdmans, R. Janknegt, E. Weil, 1997, Urology.

Impaired arterial reactivity following cytomegalovirus infection in the immunosuppressed rat

H. S. Boudier, J. Smits, P. Eerdmans, 1996, British journal of pharmacology.

Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk

M. Price, S. Pocock, N. Stockbridge, 2019, European heart journal.

Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention

M. Price, S. Pocock, N. Stockbridge, 2019, Circulation.

Mechanisms of renal vasoconstriction following furosemide in conscious rats

B. Janssen, J. Smits, P. Eerdmans, 1994, Naunyn-Schmiedeberg's Archives of Pharmacology.

The outcome of bifurcation lesion stenting using a biolimus-eluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer.

F. Eberli, P. Serruys, J. Wykrzykowska, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

F. Eberli, P. Serruys, S. Windecker, 2008, The Lancet.

Outcomes following implantation of the biolimus A9‐eluting BioMatrix coronary stent: Primary analysis of the e‐BioMatrix registry

F. Eberli, I. Menown, M. Roffi, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial

F. Eberli, P. Serruys, S. Windecker, 2011, The Lancet.

The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer.

F. Eberli, P. Serruys, S. Garg, 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

A patient with angina at night: core curriculum chapters 3 (non-invasive imaging) and 9 (chronic ischaemic heart disease)

F. Eberli, A. Wieczorek, A. Kastrati, 2012 .

The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer.

F. Eberli, P. Serruys, M. Joner, 2010 .

Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent

M. Morice, W. Wijns, P. Buszman, 2013, JACC. Cardiovascular interventions.